Product Overview
Recombinant HIV Type-O Envelope
Specificity
Immunoreactive with all sera of HIV Type-O infected individuals.
Tag/Conjugate
Unconjugated
Purity
Protein is > 95% pure as determined by 10% PAGE (coomassie staining) and RP-HPLC.
Concentration
1mg/ml, 20mM PBS pH 7.8, NaCl 0.5M, DTT 1mM, 8M urea and 0.4M imidasole.
Storage
2-8°C short term, -20°C long term
Introduction
Human immunodeficiency virus (HIV) is a lentivirus (a member of the retrovirus family) that causes acquired immunodeficiency syndrome (AIDS), a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells. The four major routes of transmission are unsafe sex, contaminated needles, breast milk, and transmission from an infected mother to her baby at birth (perinatal transmission). Screening of blood products for HIV has largely eliminated transmission through blood transfusions or infected blood products in the developed world.
Keywords
Envelope Antigen; Human immunodeficiency virus 1; Human immunodeficiency virus type O Envelope Antigen; HIV-1; Human Immunodeficiency Virus Type 1; HIV-1 Envelope Antigen; Human Immunodeficiency Virus Type O Envelope Antigen; Retroviridae; Lentivirus; Env
Citations
Publication ()
Have you cited DAG4263 in a publication?
Let us know and earn a reward for your research.
COA
Loading ......
